Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5183104
Max Phase: Preclinical
Molecular Formula: C47H60Cl4N6O11S2
Molecular Weight: 1090.97
Associated Items:
ID: ALA5183104
Max Phase: Preclinical
Molecular Formula: C47H60Cl4N6O11S2
Molecular Weight: 1090.97
Associated Items:
Canonical SMILES: CN1Cc2c(Cl)cc(Cl)cc2C(c2ccc(S(=O)(=O)NCCOCCOCCNC(=O)C(O)C(O)NCCOCCOCCNS(=O)(=O)c3ccc(C4CN(C)Cc5c(Cl)cc(Cl)cc54)cc3)cc2)C1
Standard InChI: InChI=1S/C47H60Cl4N6O11S2/c1-56-27-39(37-23-33(48)25-43(50)41(37)29-56)31-3-7-35(8-4-31)69(61,62)54-13-17-67-21-19-65-15-11-52-46(59)45(58)47(60)53-12-16-66-20-22-68-18-14-55-70(63,64)36-9-5-32(6-10-36)40-28-57(2)30-42-38(40)24-34(49)26-44(42)51/h3-10,23-26,39-40,45-46,52,54-55,58-59H,11-22,27-30H2,1-2H3,(H,53,60)
Standard InChI Key: DPFILQZMXPDPFY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1090.97 | Molecular Weight (Monoisotopic): 1088.2516 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Jacobs JW, Leadbetter MR, Bell N, Koo-McCoy S, Carreras CW, He L, Kohler J, Kozuka K, Labonté ED, Navre M, Spencer AG, Charmot D.. (2022) Discovery of Tenapanor: A First-in-Class Minimally Systemic Inhibitor of Intestinal Na+/H+ Exchanger Isoform 3., 13 (7.0): [PMID:35859876] [10.1021/acsmedchemlett.2c00037] |
Source(1):